Axsome Therapeutics Inc (AXSM)
Healthcare
Biotechnology
211.00 $
-3.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Axsome Therapeutics Inc (AXSM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -55 | -54 | -30 | -53 | -30 | -19 | -26 | -43 | -32 | 1.0 | -19 | -21 | -71 | |
| 1.4 | 1.7 | 1.7 | 1.8 | 2.0 | 2.1 | 2.1 | 1.7 | 1.7 | 2.4 | 2.3 | 2.4 | 8.8 | |
| 16 | 15 | 19 | 20 | 21 | 22 | 22 | 23 | 25 | 23 | 23 | 23 | 94 | |
| 16 | 15 | – | – | – | – | – | – | – | – | – | – | – | |
| -13 | -9.0 | 3.4 | -6.8 | 23 | -16 | 13 | -10 | -14 | 8.8 | -6.8 | 17 | 4.7 | |
| 0.1 | 0.4 | 0.0 | 0.1 | 0.1 | 0.2 | 0.0 | 0.3 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 | |
| -0.1 | -0.4 | 0.0 | -0.1 | -0.1 | -0.1 | 0.0 | -0.3 | 0.0 | -0.1 | -0.1 | -0.1 | -0.3 | |
| 29 | 1.2 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.3 | -0.4 | -0.3 | -1.6 | -1.3 | 2.9 | – | – | – | – | – | – | – | |
| 30 | – | – | – | – | -0.3 | -0.3 | -0.4 | -2.5 | -0.7 | -0.5 | -0.7 | -4.4 | |
| 246 | 33 | 0.0 | -1.2 | 14 | 30 | 14 | 29 | 35 | 21 | 16 | 3.0 | 75 | |
| 191 | -21 | -30 | -55 | -16 | 12 | -12 | -14 | 2.1 | 22 | -2.3 | -18 | 4.2 | |
| -55 | -54 | -30 | -54 | -30 | -18 | -26 | -44 | -32 | 1.0 | -19 | -21 | -71 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.